---
schema_version: "secwatch.filing_event.v1"
accession: "0000097745-22-000003"
form_type: "8-K"
ticker: "TMO"
cik: "0000097745"
company_name: "THERMO FISHER SCIENTIFIC INC."
filed_at: "2022-02-02T23:59:59+00:00"
generated_at: "2026-06-27T12:43:57.450349+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Thermo Fisher Q4 revenue $10.70B, adj EPS $6.54; full-year rev up 22% to $39.21B

## Summary
- Q4 GAAP diluted EPS $4.17 (vs $6.24); adjusted EPS $6.54 (vs $7.09); COVID-19 response rev $2.45B.
- Full-year GAAP diluted EPS $19.46 (+22%); adjusted EPS $25.13 (+28%); COVID-19 response rev $9.23B.
- Base business organic growth 8% in Q4, 14% for full year; acquisitions added 6% and 3%, respectively.
- Invested $24B in 2021 strategic acquisitions (PPD, PeproTech); returned $2.4B to shareholders via buybacks and dividends.
- 2022 financial guidance to be provided during earnings call; no specific numbers in release.

## SEC filing metadata
- accession: 0000097745-22-000003
- form_type: 8-K
- ticker: TMO
- cik: 0000097745
- company_name: THERMO FISHER SCIENTIFIC INC.
- filed_at: 2022-02-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/97745/000009774522000003/0000097745-22-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/97745/000009774522000003/tmo-20220202.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000097745-22-000003
- JSON: https://secwatch.observer/filing/0000097745-22-000003.json
- Plain text: https://secwatch.observer/filing/0000097745-22-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.